Neukio Biotherapeutics
PrivateLast Round
Series A
Sep 2, 2022
Total Funding Raised
$90M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Neukio Biotherapeutics is a biotechnology company that develops iPSC-derived cell technology platforms and next-generation off-the-shelf immune cell products for treating solid tumors and autoimmune diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Neukio Biotherapeutics Comparables
Compare Neukio Biotherapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| CellOrigin Biotech | 89% | |
| Therabest | 88% | |
| Shoreline Biosciences | 84% | |
Neukio Biotherapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Sep 2, 2022 | ||||
| Angel | Jul 29, 2021 |
Neukio Biotherapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Alwin Capital | Series A |
| IDG Capital | Angel, Series A |
| Lilly Asia Ventures | Series A, Angel |
| Sherpa Healthcare Partners | Series A |
| CD Capital | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 5, 2026
Monthly visitors increased 137% MoM.
- Nov 9, 2025
Monthly visitors increased 531% MoM to 1.6K.
Neukio Biotherapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Neukio Biotherapeutics's valuation, stock price, and market status.